Showing 1 - 9 results of 9 for search 'Benjamin L. Viglianti', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response. by David S Terman, Benjamin L Viglianti, Rahima Zennadi, Diane Fels, Richard J Boruta, Hong Yuan, Mathew R Dreher, Gerald Grant, Zahid N Rabbani, Ejung Moon, Lan Lan, Joseph Eble, Yiting Cao, Brian Sorg, Kathleen Ashcraft, Greg Palmer, Marilyn J Telen, Mark W Dewhirst
Published 2013-01-01
Article -
8
Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort o... by Aaron R. Hansen, Stephan Probst, Jean-Mathieu Beauregard, Benjamin L. Viglianti, Jeff M. Michalski, Scott T. Tagawa, Oliver Sartor, Ronald F. Tutrone, Orhan K. Oz, Kevin D. Courtney, Ebrahim S. Delpassand, Luke T. Nordquist, Medhat M. Osman, Kim N. Chi, Richard Sparks, Noble George, Sara M. Hawley, Wenting Wu, Jessica D. Jensen, Neil E. Fleshner
Published 2025-01-01
Article -
9
Investigating the SPECT Dose-Function Metrics Associated With Radiation-Induced Lung Toxicity Risk in Patients With Non-small Cell Lung Cancer Undergoing Radiation Therapy by Daniel R. Owen, BS, Yilun Sun, PhD, Philip S. Boonstra, PhD, Matthew McFarlane, MD, PhD, Benjamin L. Viglianti, MD, PhD, James M. Balter, PhD, Issam El Naqa, PhD, Matthew J. Schipper, PhD, Caitlin A. Schonewolf, MD, Randall K. Ten Haken, PhD, Feng-Ming S. Kong, MD, PhD, Shruti Jolly, MD, Martha M. Matuszak, PhD
Published 2021-05-01
Article